Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Uhlin

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Clinical & Translational Immunology|March 10, 2025
γδ T cell characterisation in the long term after haematopoietic stem cell transplantation and its impact on CMV control and cGVHD severityFaisal Alagrafi, Arwen Stikvoort, Ahmed Gaballa, et al.
Vox Sanguinis|August 13, 2019
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantationSofia Berglund, Emma Watz, Mats Remberger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantationMantas Okas, Jens Gertow, Mehmet Uzunel, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytesLaszlo Markasz, Henriette Skribek, Michael Uhlin, et al.
Transplantation|March 25, 2009
Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantationMichael Uhlin, Mantas Okas, Helen Karlsson, et al.
Cytotherapy|June 8, 2025
The donor genetic determinant of human thymopoiesis rs2204985 is associated with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipientsLucas C M Arruda, Ahmed Gaballa, Marie Schaffer, et al.
Stem Cells and Development|August 25, 2011
Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantationMichael Uhlin, Darius Sairafi, Sofia Berglund, et al.
European Journal of Haematology|September 15, 2012
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disordersOlle Ringdén, Mats Remberger, Göran Dahllöf, et al.
The Prostate|August 12, 2014
Novel method to characterize immune cells from human prostate tissueMelissa M Norström, Emelie Rådestad, Arwen Stikvoort, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Clinical & Translational Immunology|March 10, 2025
γδ T cell characterisation in the long term after haematopoietic stem cell transplantation and its impact on CMV control and cGVHD severityFaisal Alagrafi, Arwen Stikvoort, Ahmed Gaballa, et al.
Vox Sanguinis|August 13, 2019
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantationSofia Berglund, Emma Watz, Mats Remberger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantationMantas Okas, Jens Gertow, Mehmet Uzunel, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytesLaszlo Markasz, Henriette Skribek, Michael Uhlin, et al.
Transplantation|March 25, 2009
Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantationMichael Uhlin, Mantas Okas, Helen Karlsson, et al.
Cytotherapy|June 8, 2025
The donor genetic determinant of human thymopoiesis rs2204985 is associated with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipientsLucas C M Arruda, Ahmed Gaballa, Marie Schaffer, et al.
Stem Cells and Development|August 25, 2011
Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantationMichael Uhlin, Darius Sairafi, Sofia Berglund, et al.
European Journal of Haematology|September 15, 2012
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disordersOlle Ringdén, Mats Remberger, Göran Dahllöf, et al.
The Prostate|August 12, 2014
Novel method to characterize immune cells from human prostate tissueMelissa M Norström, Emelie Rådestad, Arwen Stikvoort, et al.
Pageof 11